In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008

Por Walkty, A., DeCorby, M., Nichol, K., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Publicado em 2009

In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

Por Walkty, A., DeCorby, M., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Publicado em 2011

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

Por Walkty, A., Karlowsky, J. A., Adam, H., Baxter, M., Lagacé-Wiens, P., Hoban, D. J., Zhanel, G. G.
Publicado em 2013

Evaluation of an Algorithmic Approach in Comparison with the Illumigene Assay for Laboratory Diagnosis of Clostridium difficile Infection

Por Walkty, A., Lagacé-Wiens, P. R. S., Manickam, K., Adam, H., Pieroni, P., Hoban, D., Karlowsky, J. A., Alfa, M.
Publicado em 2013

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Por Walkty, A., Adam, H., Baxter, M., Denisuik, A., Lagacé-Wiens, P., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Publicado em 2014

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactama...

Por Lagacé-Wiens, P. R. S., Tailor, F., Simner, P., DeCorby, M., Karlowsky, J. A., Walkty, A., Hoban, D. J., Zhanel, G. G.
Publicado em 2011